[250 Pages Report] The global microencapsulated omega-3 powders market size is likely to exceed US$ 17.4 Bn in 2032 and exhibit steady growth at a CAGR of 8.2% in the forecast period from 2022 to 2032. Increasing product consumption on the back of changing dietary habits and rising prevalence of cardiovascular diseases is set to push growth.
As per a report by FMI, demand for microencapsulated omega-3 powders is projected to reach US$ 10.5 Bn in 2022. Surging investment by consumers in products associated with their healthcare and wellbeing is anticipated to bode well for the market.
| Report Attribute | Details |
|---|---|
| Microencapsulated Omega-3 Powders Market Estimated Base Year Value (2021) | US$ 9.1 Billion |
| Microencapsulated Omega-3 Powders Market Expected Market Value (2022) | US$ 10.5 Billion |
| Microencapsulated Omega-3 Powders Market Anticipated Forecast Value (2032) | US$ 17.4 Billion |
| Microencapsulated Omega-3 Powders Market Projected Growth Rate (2022-2032) | 8.2% CAGR |
As omega-3 fatty acids help in lowering the risk of arrhythmias or abnormal heartbeats that can even lead to sudden death of patients, demand for omega-3 powders is set to surge in the assessment period. The emergence of microencapsulation technology that is capable of improving the durability of powders even in temperature extremities is likely to push growth.
Besides, the ability of omega-3 fatty acids to lower the levels of triglyceride, reduce blood pressure levels, and slow down the growth of atherosclerotic plaque is expected to propel sales of microencapsulated omega-3 powders in future years. Increasing inclination of consumers towards healthier alternatives and surging adoption of preventive care to lead a better lifestyle are also set to boost growth.
In addition to that, high demand for omega-3 supplements worldwide as they are considered to be a rich source of minerals, proteins, and vitamins is estimated to foster growth. Increasing need to lower the risk of depression, asthma, and cancer among people of all age groups is also likely to drive the market.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Increasing prevalence of cancer and cardiovascular disease stoked by rising health awareness and adoption of a sedentary lifestyle across the globe is anticipated to spur the microencapsulated omega-3 powders market growth in the upcoming years. As per the World Health Organization (WHO), in 2020, cancer accounted for about 10 million deaths or 1 in 6 deaths worldwide. These numbers are projected to surge at a rapid pace in future years, thereby accelerating the market.
The WHO further mentioned that diabetes was considered to be the ninth leading cause of death in 2019, with a projected 1.5 million deaths directly caused by the disease. Also, the number of people suffering from diabetes surged to 422 million in 2014 from 422 million in 2014 with high prevalence in low- and middle-income countries globally. The trend is set to continue during the forthcoming years with changing lifestyles and consumption of junk food, thereby fostering growth.
Conventional omega 3 ingredient producers, especially in emerging economies, find it difficult to provide their products at a competitive price range. It is more relevant for those manufacturers that deliver omega-3 ingredients from alternative sources, such as krill oils and algae oils. Apart from that, consuming very high amounts of omega-3 fatty acids with health supplements can surge blood sugar levels of those people living with diabetes.
Diarrhea is another common side effect of consuming excessive fish oil. Driven by the above-mentioned disadvantages, demand for microencapsulated omega-3 powders may decline in future.
Principal Consultant
North America is anticipated to dominate in the evaluation period by generating the largest microencapsulated omega-3 powders market share. Increasing cases of heart-related issues and obesity in the U.S. and Canada are set to push the need for various health supplements, including microencapsulated omega-3 powders across North America.
Moreover, several manufacturers based in the region are focusing more on developing advanced production technologies. They are thus aiming to reduce oxidation in their manufacturing processes and eliminate environmental pollutants from fish oil. A few North America-based producers are also striving to concentrate omega-3 content in their final products to ensure the delivery of healthy parameters of fish oil.
Increasing awareness among people living in India, China, South Korea, and Japan regarding the benefits of following a healthy diet is projected to augment the Asia Pacific microencapsulated omega-3 powders market size. Increasing population of young mothers and high birth rate across Asia Pacific are also set to spur the demand for infant nutrition, thereby pushing sales.
Additionally, increasing shift of consumers towards plant-based alternatives is compelling manufacturers to produce algae oil-based supplements. Growing vegan population across Asia Pacific is set to fuel sales of plant-based casing materials.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
Some of the prominent companies operating in the global microencapsulated omega-3 powders market include Clover Corporation, Venketesh Biosciences LLP, Novotech Nutrition, Socius Ingredients, Koninklijke DSM N.V., KD Pharma Group, BASF SE, Wincobel, Skuny Bioscience Co., Ltd., Stepan Company, Glanbia Nutritionals, Biosearch SA and Benexia among others.
The global market is highly competitive in nature with the presence of various local and international key players. They are mainly focusing on developing well-differentiated products to generate high market share. Some of the other key players are aiming to use non-fish sources for omega-3 extraction backed by the increasing trend of veganism in various parts of the globe. They are striving to find new algal sources as these do not have a fishy odor or taste, thereby making omega-3 ideal for the vegan population.
| Report Attribute | Details |
|---|---|
| Growth Rate | CAGR of 8.2% from 2022 to 2032 |
| Base Year for Estimation | 2021 |
| Historical Data | 2015-2020 |
| Forecast Period | 2022-2032 |
| Quantitative Units | Revenue in US$ Million and CAGR from 2022-2032 |
| Report Coverage | Revenue Forecast, Volume Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends and Pricing Analysis |
| Segments Covered |
|
| Regions Covered |
|
| Key Countries Profiled |
|
| Key Companies Profiled |
|
| Customization | Available Upon Request |
The global microencapsulated omega-3 powders market is set to surpass US$ 17.4 Bn in 2032.
North America is set to lead the microencapsulated omega-3 powders market in the forecast period.
Clover Corporation, Venketesh Biosciences LLP, Novotech Nutrition, Socius Ingredients, Koninklijke DSM N.V., KD Pharma Group, BASF SE, and Wincobel some of the renowned companies in the microencapsulated omega-3 powders market.
1. Executive Summary
1.1. Global Market Outlook
1.2. Demand-side Trends
1.3. Supply-side Trends
1.4. Technology Roadmap Analysis
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Background
3.1. Market Dynamics
3.1.1. Drivers
3.1.2. Restraints
3.1.3. Opportunity
3.1.4. Trends
3.2. Scenario Forecast
3.2.1. Demand in Optimistic Scenario
3.2.2. Demand in Likely Scenario
3.2.3. Demand in Conservative Scenario
3.3. Opportunity Map Analysis
3.4. Product Life Cycle Analysis
3.5. Supply Chain Analysis
3.5.1. Supply Side Participants and their Roles
3.5.1.1. Producers
3.5.1.2. Mid-Level Participants (Traders/ Agents/ Brokers)
3.5.1.3. Wholesalers and Distributors
3.5.2. Value Added and Value Created at Node in the Supply Chain
3.5.3. List of Raw Material Suppliers
3.5.4. List of Existing and Potential Buyer’s
3.6. Investment Feasibility Matrix
3.7. Value Chain Analysis
3.7.1. Profit Margin Analysis
3.7.2. Wholesalers and Distributors
3.7.3. Retailers
3.8. PESTLE and Porter’s Analysis
3.9. Regulatory Landscape
3.9.1. By Key Regions
3.9.2. By Key Countries
3.10. Regional Parent Market Outlook
3.11. Production and Consumption Statistics
3.12. Import and Export Statistics
4. Global Microencapsulated Omega-3 Powders Market Analysis 2017-2021 and Forecast, 2022-2032
4.1. Historical Market Size Value (US$ Mn) & Volume (Tons) Analysis, 2017-2021
4.2. Current and Future Market Size Value (US$ Mn) & Volume (Tons) Projections, 2022-2032
4.2.1. Y-o-Y Growth Trend Analysis
4.2.2. Absolute $ Opportunity Analysis
5. Global Microencapsulated Omega-3 Powders Market Analysis 2017-2021 and Forecast 2022-2032, By Nature
5.1. Introduction / Key Findings
5.2. Historical Market Size Value (US$ Mn) & Volume (Tons) Analysis By Nature, 2017-2021
5.3. Current and Future Market Size Value (US$ Mn) & Volume (Tons) Analysis and Forecast By Nature, 2022-2032
5.3.1. Organic
5.3.2. Conventional
5.4. Y-o-Y Growth Trend Analysis By Nature, 2017-2021
5.5. Absolute $ Opportunity Analysis By Nature, 2022-2032
6. Global Microencapsulated Omega-3 Powders Market Analysis 2017-2021 and Forecast 2022-2032, By Distribution Channel
6.1. Introduction / Key Findings
6.2. Historical Market Size Value (US$ Mn) & Volume (Tons) Analysis By Distribution Channel, 2017-2021
6.3. Current and Future Market Size Value (US$ Mn) & Volume (Tons) Analysis and Forecast By Distribution Channel, 2022-2032
6.3.1. Direct
6.3.2. Indirect
6.3.2.1. Store-based
6.3.2.2. Supermarket/Hypermarket
6.3.2.3. Convenience Stores
6.3.2.4. Discount Stores
6.3.2.5. Food and Drink Health Stores
6.3.2.6. Online
6.4. Y-o-Y Growth Trend Analysis By Distribution Channel, 2017-2021
6.5. Absolute $ Opportunity Analysis By Distribution Channel, 2022-2032
7. Global Microencapsulated Omega-3 Powders Market Analysis 2017-2021 and Forecast 2022-2032, By Type
7.1. Introduction / Key Findings
7.2. Historical Market Size Value (US$ Mn) & Volume (Tons) Analysis By Type, 2017-2021
7.3. Current and Future Market Size Value (US$ Mn) & Volume (Tons) Analysis and Forecast By Type, 2022-2032
7.3.1. Alpha-linolenic Acid
7.3.2. Eicosapentaenoic Acid
7.3.3. Docosahexaenoic Acid
7.4. Y-o-Y Growth Trend Analysis By Type, 2017-2021
7.5. Absolute $ Opportunity Analysis By Type, 2022-2032
8. Global Microencapsulated Omega-3 Powders Market Analysis 2017-2021 and Forecast 2022-2032, By Region
8.1. Introduction
8.2. Historical Market Size Value (US$ Mn) & Volume (Tons) Analysis By Region, 2017-2021
8.3. Current Market Size Value (US$ Mn) & Volume (Tons) Analysis and Forecast By Region, 2022-2032
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. MEA
8.4. Market Attractiveness Analysis By Region
9. North America Microencapsulated Omega-3 Powders Market Analysis 2017-2021 and Forecast 2022-2032, By Country
9.1. Historical Market Size Value (US$ Mn) & Volume (Tons) Trend Analysis By Market Taxonomy, 2017-2021
9.2. Market Size Value (US$ Mn) & Volume (Tons) Forecast By Market Taxonomy, 2022-2032
9.2.1. By Country
9.2.1.1. U.S.
9.2.1.2. Canada
9.2.2. By Nature
9.2.3. By Distribution Channel
9.2.4. By Type
9.3. Market Attractiveness Analysis
9.3.1. By Country
9.3.2. By Nature
9.3.3. By Distribution Channel
9.3.4. By Type
9.4. Key Takeaways
10. Latin America Microencapsulated Omega-3 Powders Market Analysis 2017-2021 and Forecast 2022-2032, By Country
10.1. Historical Market Size Value (US$ Mn) & Volume (Tons) Trend Analysis By Market Taxonomy, 2017-2021
10.2. Market Size Value (US$ Mn) & Volume (Tons) Forecast By Market Taxonomy, 2022-2032
10.2.1. By Country
10.2.1.1. Brazil
10.2.1.2. Mexico
10.2.1.3. Rest of Latin America
10.2.2. By Nature
10.2.3. By Distribution Channel
10.2.4. By Type
10.3. Market Attractiveness Analysis
10.3.1. By Country
10.3.2. By Nature
10.3.3. By Distribution Channel
10.3.4. By Type
10.4. Key Takeaways
11. Europe Microencapsulated Omega-3 Powders Market Analysis 2017-2021 and Forecast 2022-2032, By Country
11.1. Historical Market Size Value (US$ Mn) & Volume (Tons) Trend Analysis By Market Taxonomy, 2017-2021
11.2. Market Size Value (US$ Mn) & Volume (Tons) Forecast By Market Taxonomy, 2022-2032
11.2.1. By Country
11.2.1.1. Germany
11.2.1.2. U.K.
11.2.1.3. France
11.2.1.4. Spain
11.2.1.5. Italy
11.2.1.6. Rest of Europe
11.2.2. By Nature
11.2.3. By Distribution Channel
11.2.4. By Type
11.3. Market Attractiveness Analysis
11.3.1. By Country
11.3.2. By Nature
11.3.3. By Distribution Channel
11.3.4. By Type
11.4. Key Takeaways
12. Asia Pacific Microencapsulated Omega-3 Powders Market Analysis 2017-2021 and Forecast 2022-2032, By Country
12.1. Historical Market Size Value (US$ Mn) & Volume (Tons) Trend Analysis By Market Taxonomy, 2017-2021
12.2. Market Size Value (US$ Mn) & Volume (Tons) Forecast By Market Taxonomy, 2022-2032
12.2.1. By Country
12.2.1.1. China
12.2.1.2. Japan
12.2.1.3. South Korea
12.2.1.4. Malaysia
12.2.1.5. Singapore
12.2.1.6. Australia
12.2.1.7. New Zealand
12.2.1.8. Rest of APAC
12.2.2. By Nature
12.2.3. By Distribution Channel
12.2.4. By Type
12.3. Market Attractiveness Analysis
12.3.1. By Country
12.3.2. By Nature
12.3.3. By Distribution Channel
12.3.4. By Type
12.4. Key Takeaways
13. MEA Microencapsulated Omega-3 Powders Market Analysis 2017-2021 and Forecast 2022-2032, By Country
13.1. Historical Market Size Value (US$ Mn) & Volume (Tons) Trend Analysis By Market Taxonomy, 2017-2021
13.2. Market Size Value (US$ Mn) & Volume (Tons) Forecast By Market Taxonomy, 2022-2032
13.2.1. By Country
13.2.1.1. GCC Countries
13.2.1.2. South Africa
13.2.1.3. Israel
13.2.1.4. Rest of MEA
13.2.2. By Nature
13.2.3. By Distribution Channel
13.2.4. By Type
13.3. Market Attractiveness Analysis
13.3.1. By Country
13.3.2. By Nature
13.3.3. By Distribution Channel
13.3.4. By Type
13.4. Key Takeaways
14. Key Countries Microencapsulated Omega-3 Powders Market Analysis
14.1. U.S.
14.1.1. Pricing Analysis
14.1.2. Market Share Analysis, 2021
14.1.2.1. By Nature
14.1.2.2. By Distribution Channel
14.1.2.3. By Type
14.2. Canada
14.2.1. Pricing Analysis
14.2.2. Market Share Analysis, 2021
14.2.2.1. By Nature
14.2.2.2. By Distribution Channel
14.2.2.3. By Type
14.3. Brazil
14.3.1. Pricing Analysis
14.3.2. Market Share Analysis, 2021
14.3.2.1. By Nature
14.3.2.2. By Distribution Channel
14.3.2.3. By Type
14.4. Mexico
14.4.1. Pricing Analysis
14.4.2. Market Share Analysis, 2021
14.4.2.1. By Nature
14.4.2.2. By Distribution Channel
14.4.2.3. By Type
14.5. Germany
14.5.1. Pricing Analysis
14.5.2. Market Share Analysis, 2021
14.5.2.1. By Nature
14.5.2.2. By Distribution Channel
14.5.2.3. By Type
14.6. U.K.
14.6.1. Pricing Analysis
14.6.2. Market Share Analysis, 2021
14.6.2.1. By Nature
14.6.2.2. By Distribution Channel
14.6.2.3. By Type
14.7. France
14.7.1. Pricing Analysis
14.7.2. Market Share Analysis, 2021
14.7.2.1. By Nature
14.7.2.2. By Distribution Channel
14.7.2.3. By Type
14.8. Spain
14.8.1. Pricing Analysis
14.8.2. Market Share Analysis, 2021
14.8.2.1. By Nature
14.8.2.2. By Distribution Channel
14.8.2.3. By Type
14.9. Italy
14.9.1. Pricing Analysis
14.9.2. Market Share Analysis, 2021
14.9.2.1. By Nature
14.9.2.2. By Distribution Channel
14.9.2.3. By Type
14.10. China
14.10.1. Pricing Analysis
14.10.2. Market Share Analysis, 2021
14.10.2.1. By Nature
14.10.2.2. By Distribution Channel
14.10.2.3. By Type
14.11. Japan
14.11.1. Pricing Analysis
14.11.2. Market Share Analysis, 2021
14.11.2.1. By Nature
14.11.2.2. By Distribution Channel
14.11.2.3. By Type
14.12. South Korea
14.12.1. Pricing Analysis
14.12.2. Market Share Analysis, 2021
14.12.2.1. By Nature
14.12.2.2. By Distribution Channel
14.12.2.3. By Type
14.13. Malaysia
14.13.1. Pricing Analysis
14.13.2. Market Share Analysis, 2021
14.13.2.1. By Nature
14.13.2.2. By Distribution Channel
14.13.2.3. By Type
14.14. Singapore
14.14.1. Pricing Analysis
14.14.2. Market Share Analysis, 2021
14.14.2.1. By Nature
14.14.2.2. By Distribution Channel
14.14.2.3. By Type
14.15. Australia
14.15.1. Pricing Analysis
14.15.2. Market Share Analysis, 2021
14.15.2.1. By Nature
14.15.2.2. By Distribution Channel
14.15.2.3. By Type
14.16. New Zealand
14.16.1. Pricing Analysis
14.16.2. Market Share Analysis, 2021
14.16.2.1. By Nature
14.16.2.2. By Distribution Channel
14.16.2.3. By Type
14.17. GCC Countries
14.17.1. Pricing Analysis
14.17.2. Market Share Analysis, 2021
14.17.2.1. By Nature
14.17.2.2. By Distribution Channel
14.17.2.3. By Type
14.18. South Africa
14.18.1. Pricing Analysis
14.18.2. Market Share Analysis, 2021
14.18.2.1. By Nature
14.18.2.2. By Distribution Channel
14.18.2.3. By Type
14.19. Israel
14.19.1. Pricing Analysis
14.19.2. Market Share Analysis, 2021
14.19.2.1. By Nature
14.19.2.2. By Distribution Channel
14.19.2.3. By Type
15. Market Structure Analysis
15.1. Competition Dashboard
15.2. Competition Benchmarking
15.3. Market Share Analysis of Top Players
15.3.1. By Regional
15.3.2. By Nature
15.3.3. By Distribution Channel
15.3.4. By Type
16. Competition Analysis
16.1. Competition Deep Dive
16.1.1. KD Pharma Group
16.1.1.1. Overview
16.1.1.2. Product Portfolio
16.1.1.3. Profitability by Market Segments
16.1.1.4. Sales Footprint
16.1.1.5. Strategy Overview
16.1.1.5.1. Marketing Strategy
16.1.1.5.2. Product Strategy
16.1.1.5.3. Channel Strategy
16.1.2. Venketesh Biosciences LLP
16.1.2.1. Overview
16.1.2.2. Product Portfolio
16.1.2.3. Profitability by Market Segments
16.1.2.4. Sales Footprint
16.1.2.5. Strategy Overview
16.1.2.5.1. Marketing Strategy
16.1.2.5.2. Product Strategy
16.1.2.5.3. Channel Strategy
16.1.3. Wincobel
16.1.3.1. Overview
16.1.3.2. Product Portfolio
16.1.3.3. Profitability by Market Segments
16.1.3.4. Sales Footprint
16.1.3.5. Strategy Overview
16.1.3.5.1. Marketing Strategy
16.1.3.5.2. Product Strategy
16.1.3.5.3. Channel Strategy
16.1.4. Stepan Company
16.1.4.1. Overview
16.1.4.2. Product Portfolio
16.1.4.3. Profitability by Market Segments
16.1.4.4. Sales Footprint
16.1.4.5. Strategy Overview
16.1.4.5.1. Marketing Strategy
16.1.4.5.2. Product Strategy
16.1.4.5.3. Channel Strategy
16.1.5. Socius Ingredients
16.1.5.1. Overview
16.1.5.2. Product Portfolio
16.1.5.3. Profitability by Market Segments
16.1.5.4. Sales Footprint
16.1.5.5. Strategy Overview
16.1.5.5.1. Marketing Strategy
16.1.5.5.2. Product Strategy
16.1.5.5.3. Channel Strategy
16.1.6. Benexia
16.1.6.1. Overview
16.1.6.2. Product Portfolio
16.1.6.3. Profitability by Market Segments
16.1.6.4. Sales Footprint
16.1.6.5. Strategy Overview
16.1.6.5.1. Marketing Strategy
16.1.6.5.2. Product Strategy
16.1.6.5.3. Channel Strategy
16.1.7. Biosearch
16.1.7.1. Overview
16.1.7.2. Product Portfolio
16.1.7.3. Profitability by Market Segments
16.1.7.4. Sales Footprint
16.1.7.5. Strategy Overview
16.1.7.5.1. Marketing Strategy
16.1.7.5.2. Product Strategy
16.1.7.5.3. Channel Strategy
16.1.8. Glanbia Nutritionals
16.1.8.1. Overview
16.1.8.2. Product Portfolio
16.1.8.3. Profitability by Market Segments
16.1.8.4. Sales Footprint
16.1.8.5. Strategy Overview
16.1.8.5.1. Marketing Strategy
16.1.8.5.2. Product Strategy
16.1.8.5.3. Channel Strategy
16.1.9. Clover Corporation
16.1.9.1. Overview
16.1.9.2. Product Portfolio
16.1.9.3. Profitability by Market Segments
16.1.9.4. Sales Footprint
16.1.9.5. Strategy Overview
16.1.9.5.1. Marketing Strategy
16.1.9.5.2. Product Strategy
16.1.9.5.3. Channel Strategy
16.1.10. Skuny Bioscience Co., Ltd.
16.1.10.1. Overview
16.1.10.2. Product Portfolio
16.1.10.3. Profitability by Market Segments
16.1.10.4. Sales Footprint
16.1.10.5. Strategy Overview
16.1.10.5.1. Marketing Strategy
16.1.10.5.2. Product Strategy
16.1.10.5.3. Channel Strategy
16.1.11. BASF SE
16.1.11.1. Overview
16.1.11.2. Product Portfolio
16.1.11.3. Profitability by Market Segments
16.1.11.4. Sales Footprint
16.1.11.5. Strategy Overview
16.1.11.5.1. Marketing Strategy
16.1.11.5.2. Product Strategy
16.1.11.5.3. Channel Strategy
16.1.12. Novotech Nutrition
16.1.12.1. Overview
16.1.12.2. Product Portfolio
16.1.12.3. Profitability by Market Segments
16.1.12.4. Sales Footprint
16.1.12.5. Strategy Overview
16.1.12.5.1. Marketing Strategy
16.1.12.5.2. Product Strategy
16.1.12.5.3. Channel Strategy
16.1.13. Koninklijke DSM N.V.
16.1.13.1. Overview
16.1.13.2. Product Portfolio
16.1.13.3. Profitability by Market Segments
16.1.13.4. Sales Footprint
16.1.13.5. Strategy Overview
16.1.13.5.1. Marketing Strategy
16.1.13.5.2. Product Strategy
16.1.13.5.3. Channel Strategy
17. Assumptions & Acronyms Used
18. Research Methodology
Explore Food and Beverage Insights
View Reports
Microencapsulated Omega-3 Powders Market
